SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

NMUS RSS Feed
Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: MasterBlastr, Paulieme, miracleshappen
Search This Board: 
Last Post: 4/30/2017 12:09:26 AM - Followers: 106 - Board type: Free - Posts Today: 1


 

 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:  http://www.nemusbioscience.com/home.html

Filings and disclosure with Level 2 quotes:  http://www.otcmarkets.com/stock/NMUS/quote

Contact:

(949) 396-0330
E-MAIL: BRIAN@NEMUSBIO.COM
600 ANTON BLVD, SUITE 1100, COSTA MESA, CA 92626


 

Nemus Bioscience (NMUS) Presentation (47 minutes):  
https://www.youtube.com/watch?v=tYV2PEaj6os

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016: 
http://s2.q4cdn.com/753474459/files/doc_presentations/2016/Rodman-Conf-September-2016_FINAL.pdf



 


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  
 

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -


Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy


Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)

 

Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model

 

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.


NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 


CANNAINVESTOR Magazine Top 20 Cannabis Stocks 

 

NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 

 

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 

 

NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 

 

Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 

 

NMUS Security Details

Share Structure - as of Feb 1, 2017
Source: otcmarkets.com

Authorized Shares: 236,000,000
Outstanding Shares: 
22,438,163
      - Restricted  13,494,621
    - Unrestricted   8,943,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001


Transfer Agent: Clear Trust, LLC

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NMUS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
NMUS News: Amended Statement of Beneficial Ownership (sc 13d/a) 03/28/2017 04:24:31 PM
NMUS News: Statement of Changes in Beneficial Ownership (4) 03/28/2017 10:53:24 AM
NMUS News: Notice of Effectiveness (effect) 03/24/2017 06:01:45 AM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 03/23/2017 09:30:08 AM
NMUS News: Securities Registration Statement (s-1) 03/13/2017 05:29:03 PM
PostSubject
#1508  Sticky Note $NMUS / $GWPH BEST IN CLASS Oncology Potential Underrated Momostocktrades 03/06/17 07:59:34 PM
#1229  Sticky Note $NMUS February 16, 2017 NEW Investor Presentation Posted Momostocktrades 02/19/17 10:09:13 AM
#1867   That's solid analysis. I think InMed has potential Vinpat 04/30/17 12:09:26 AM
#1866   No, you just caused me to stop and AntonChigurh 04/29/17 11:29:22 PM
#1865   I see one person looking for 40 percent scottsmith 04/29/17 05:02:29 PM
#1864   I hope I didn't talk you out of Vinpat 04/29/17 04:41:29 PM
#1863   It wouldn't surprise me if the next announcement Vinpat 04/29/17 04:37:27 PM
#1862   Prove is a bit strong...however i agree wholeheartedly afterhoursearnings 04/29/17 03:59:23 PM
#1861   All good points. Its clear the price frozenspokes 04/29/17 03:57:44 PM
#1860   Well thats the thing here...at this price they afterhoursearnings 04/29/17 01:03:30 PM
#1859   PIPE death spiral financing is always a big AntonChigurh 04/29/17 01:00:44 PM
#1858   I Just pray we don't have another PR afterhoursearnings 04/29/17 12:58:55 PM
#1857   Ingram is in for $2.50 a share, says AntonChigurh 04/29/17 12:56:00 PM
#1856   Yea I think this is gonna be a afterhoursearnings 04/29/17 12:43:43 PM
#1855   Ya, Vinpat has a nice summary of the AntonChigurh 04/29/17 12:36:51 PM
#1854   And THIS is why everyone here is sticking afterhoursearnings 04/29/17 12:22:58 PM
#1853   You in this IP? scottsmith 04/29/17 11:12:03 AM
#1852   This stock is definitely a risk as all Vinpat 04/29/17 01:19:39 AM
#1851   I've read that entirely. more than once AntonChigurh 04/29/17 12:27:56 AM
#1850   True - it's on a terrible exchange which cjarmstrong 04/29/17 12:23:58 AM
#1849   you mean the 25 pages of risk disclosure? TrueTrades 04/28/17 11:43:11 PM
#1848   Its on the OTC bro, I think we AntonChigurh 04/28/17 11:14:22 PM
#1847   What makes you so confident? Read the latest cjarmstrong 04/28/17 11:04:12 PM
#1846   LOL Hollister's lawsuit! Does anyone have his initial AntonChigurh 04/28/17 11:01:58 PM
#1845   Not at all. You broke my dreams about AntonChigurh 04/28/17 11:01:14 PM
#1844   I hope you won't hold it against me. Vinpat 04/28/17 07:01:58 PM
#1843   Shhh. Let us load bro! I cant complain though, AntonChigurh 04/28/17 05:35:04 PM
#1842   Yes. When they get a partnership deal this Vinpat 04/28/17 05:18:26 PM
#1841   "We moved forward with this Series D financing JayZee4 04/28/17 03:27:55 PM
#1840   nemus coming with a partnership and nb1222 phase1? TrueTrades 04/28/17 12:12:22 PM
#1839   Haha, glad wuff is out of this. Pump AntonChigurh 04/27/17 03:57:35 PM
#1838   Thanks....I've been adding for the past few months, The Rooster 04/27/17 03:16:50 PM
#1837   Welcome to the club Keep it to yourself Bet the AntonChigurh 04/27/17 03:07:05 PM
#1836   This is a hidden GEM, can't believe I'm The Rooster 04/27/17 02:59:01 PM
#1835   so I was correct that the patent was JayZee4 04/26/17 08:04:45 PM
#1834   sitting on patent 9,630,941 for suppository and previous TrueTrades 04/26/17 03:10:31 PM
#1833   I get all the charts I like with afterhoursearnings 04/26/17 01:44:33 PM
#1832   Uhh....take a look at historical volume AntonChigurh 04/26/17 01:43:21 PM
#1831   Same here..slowly trying to reach 100k about 1/4 afterhoursearnings 04/26/17 01:34:31 PM
#1830   No one is getting my shares... AntonChigurh 04/26/17 01:23:29 PM
#1829   We are stable tho. Think next channel break afterhoursearnings 04/26/17 01:19:54 PM
#1828   We're at 52 week lows again, the company FlyingPig10 04/26/17 11:33:24 AM
#1827   OK who sold? If you have more available afterhoursearnings 04/26/17 11:16:26 AM
#1826   yes the patent is granted TrueTrades 04/25/17 08:39:59 PM
#1825   I'm not seeing anything with that number or date. AntonChigurh 04/25/17 06:52:33 PM
#1824   Correct Info: Jdanger 2 04/25/17 06:24:31 PM
#1823   OK that makes sense, I'll check it out Jdanger 2 04/25/17 05:53:37 PM
#1822   What about that patent in the link makes Jdanger 2 04/25/17 05:38:52 PM
#1821   Wtf not letting me post the right link. JayZee4 04/25/17 05:38:24 PM
#1820   Wrong link: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p= JayZee4 04/25/17 05:36:42 PM
#1819   So many BUYS this last week. Way more afterhoursearnings 04/25/17 05:34:44 PM
#1818   http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah JayZee4 04/25/17 05:27:25 PM
PostSubject